To summarize, the IDO metabolic trap hypothesis for ME/CFS suggests that substrate inhibition of IDO1 creates the possibility of metabolic bistability in cells expressing the kynurenine pathway. This evidence concerns the gene IDO1 and myalgic encephalomeyelitis/chronic fatigue syndrome.